carmustine raz 100 mg
raz pharmaceutics ltd, israel - carmustine - powder and solvent for concentrate for solution for infusion - carmustine 100 mg - carmustine - carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• multiple myeloma - in combination with glucocorticoid such as prednisone. • hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• non-hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.
rigevidon tablets
gedeon richter (uk) ltd - ethinylestradiol; levonorgestrel - oral tablet - 30microgram ; 150microgram
carmustine navinta 100 mg
mbi pharma ltd., israel - carmustine - powder and solvent for concentrate for solution for infusion - carmustine 100 mg/vial - carmustine - carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• multiple myeloma - in combination with glucocorticoid such as prednisone. • hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• non-hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy
calcium 500 tablets
martindale pharmaceuticals ltd - calcium carbonate - oral tablet - 1.25gram
carmustine obvius
k.s.kim international ltd - carmustine - powder and solvent for concentrate for solution for infusion - carmustine 100 mg - carmustine - carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• multiple myeloma - in combination with glucocorticoid such as prednisone. • hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• non-hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.
silvederma cream 1g/100g
laboratorio aldo-union s.l. baronesa de malda 73, 08950 esplugues de llobregat, barcelona, spain - sulfadiazine silver - cream - sulfadiazine silver 1 g - antibiotics and chemotherapeutics for dermatological use
myolaxin 15% solution for infusion
vetoquinol uk limited - guaifenesin - solution for infusion - 15 %w/v - equine non food - neurological preparations
primobolan s tablets
schering -
bekunis
dexcel ltd, israel - senna - dragee - senna 150-220 mg - senna glycosides - senna glycosides - laxative.
santol drops eye
liqvor cjsc - naphazoline (naphazoline hydrochloride) - drops eye - 0,3mg/ml